# Trade Mark Journal No.2026/015 10 April 2026

## WO0000001895512 (42)

Office of origin: Switzerland

Date of International Registration:18 November 2025
Date of designation in the UK: 18 November 2025

International priority date claimed: 6 October 2025 (Switzerland) (839749)

Class 42
  Provision of information regarding the development and application of AI-based tools for predicting the risk of recurrence in early-stage breast cancer.

Novartis Pharma AG